Irvine medical device maker MiCardia Corp. said Thursday it raised $9 million in a second round of financing.
HBM Biocapital, a Switzerland-based fund, led the investment.
A couple of Orange County investors took part: MedFocus Family of Funds and the BioStar Private Equity Fund LLC.
MedFocus and BioStar are connected to Michael Henson, a longtime local device entrepreneur and investor. Henson is MiCardia’s chairman.
MiCardia plans to use the money to develop implantable devices to treat late-stage congestive heart failure and mitral heart valve disease.
